s6y

3 Clarus Therapeutics Holdings, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001062993-21-008833

Documents

  1. INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 3

On sec.gov